BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3905320)

  • 1. Hepatic drug clearance following traumatic injury.
    Slaughter RL; Hassett JM
    Drug Intell Clin Pharm; 1985 Nov; 19(11):799-806. PubMed ID: 3905320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of meperidine in acute trauma patients.
    Kirkwood CF; Edwards DJ; Lalka D; Lasezkay G; Hassett JM; Slaughter RL
    J Trauma; 1986 Dec; 26(12):1090-3. PubMed ID: 3795304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neurotrauma on hepatic drug clearance.
    Boucher BA; Kuhl DA; Fabian TC; Robertson JT
    Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):487-97. PubMed ID: 1934861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of antipyrine, acetaminophen and lidocaine in fed and fasted horses.
    Engelking LR; Blyden GT; Lofstedt J; Greenblatt DJ
    J Vet Pharmacol Ther; 1987 Mar; 10(1):73-82. PubMed ID: 3586126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of food on lidocaine kinetics: mechanism of food-related alteration in high intrinsic clearance drug elimination.
    Elvin AT; Cole AF; Pieper JA; Rolbin SH; Lalka D
    Clin Pharmacol Ther; 1981 Oct; 30(4):455-60. PubMed ID: 7285479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine and lidocaine are cleared faster in horses than in humans: acetaminophen may be handled similarly.
    Engelking LR; Lofstedt J; Blyden GT; Greenblatt DJ
    Pharmacology; 1987; 34(4):192-200. PubMed ID: 3602088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of model traumatic injury on hepatic drug metabolism in the rat. I. In vivo antipyrine metabolism.
    Griffeth LK; Rosen GM; Tschanz C; Rauckman EJ
    Drug Metab Dispos; 1983; 11(6):517-25. PubMed ID: 6140133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations.
    Davies RF; Dubé LM; Mousseau N; McGilveray I; Beanlands DS
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):634-41. PubMed ID: 3172810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting quinidine protein binding in humans.
    Edwards DJ; Axelson JE; Slaughter RL; Elvin AT; Lalka D
    J Pharm Sci; 1984 Sep; 73(9):1264-7. PubMed ID: 6491948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
    Huet PM; Lelorier J
    Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of propranolol and lidocaine through the rat blood-brain barrier. Primary role of globulin-bound drug.
    Pardridge WM; Sakiyama R; Fierer G
    J Clin Invest; 1983 Apr; 71(4):900-8. PubMed ID: 6833493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapy.
    Relling MV; Crom WR; Pieper JA; Cupit GC; Rivera GK; Evans WE
    Clin Pharmacol Ther; 1987 Jun; 41(6):651-60. PubMed ID: 3472701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of model traumatic injury on hepatic drug metabolism in the rat. IV. Glucuronidation.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1985; 13(4):391-7. PubMed ID: 2863100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.
    Goolkasian DL; Slaughter RL; Edwards DJ; Lalka D
    Eur J Clin Pharmacol; 1983; 25(3):413-7. PubMed ID: 6628530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing serum protein binding of lidocaine in humans.
    McNamara PJ; Slaughter RL; Pieper JA; Wyman MG; Lalka D
    Anesth Analg; 1981 Jun; 60(6):395-400. PubMed ID: 6165258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hepatic ischaemia/reperfusion injury in a rabbit model of Indocyanine Green clearance.
    Seifalian AM; El-Desoky H; Delpy DT; Davidson BR
    Clin Sci (Lond); 2002 May; 102(5):579-86. PubMed ID: 11980578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass.
    Autschbach R; Falk V; Lange H; Oellerich M; Walther T; Mohr FW; Dalichau H
    Thorac Cardiovasc Surg; 1996 Apr; 44(2):76-80. PubMed ID: 8782332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.